Topical minoxidil dose-response effect in alopecia areata

Area of Science:

• Dermatology
• Pharmacology

Background:

• Alopecia areata is an autoimmune condition causing hair loss.
• Topical minoxidil is a common treatment for hair loss conditions.

Purpose of the Study:

• To evaluate the efficacy and safety of 5% topical minoxidil for severe alopecia areata.
• To compare the results with a previous study using 1% topical minoxidil.

Main Methods:

• 47 patients with severe alopecia areata were treated with 5% topical minoxidil solution.
• Treatment duration ranged from 48 to 60 weeks.
• Patient outcomes were compared to historical data from 1% topical minoxidil treatment.

Main Results:

• 85% of patients (40/47) experienced terminal hair regrowth.
• Hair regrowth quality was frequently not cosmetically acceptable.
• 5% minoxidil showed significantly better response rates and hair quality compared to 1% minoxidil.
• One patient developed allergic contact dermatitis; no systemic side effects were observed.

Conclusions:

• A dose-response relationship exists for topical minoxidil in treating alopecia areata.
• Higher concentrations (5%) yield better regrowth but may not be cosmetically satisfactory.
• Further research into optimized dosing and delivery systems is warranted to improve therapeutic outcomes.